SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Claudia S. Cohn, James Stubbs, Joseph Schwartz, Richard Francis, Cheryl Goss, Melissa Cushing, Beth Shaz, David Mair, Barbara Brantigan, W. Andrew Heaton, A comparison of adverse reaction rates for PAS C versus plasma platelet units, Transfusion, 2014, 54, 7
  2. 2
    William Savage, Aaron A.R. Tobian, Paul M. Ness, Richard M. Kaufman, Desensitization in allergic transfusion reactions: evidence from the Trial to Reduce Alloimmunization to Platelets, Transfusion, 2014, 54, 2
  3. You have free access to this content3
    Aaron A.R. Tobian, Alice K. Fuller, Kristin Uglik, Daniel J. Tisch, Prabhakar D. Borge, Richard J. Benjamin, Paul M. Ness, Karen E. King, The impact of platelet additive solution apheresis platelets on allergic transfusion reactions and corrected count increment (CME), Transfusion, 2014, 54, 6
  4. 4
    W. Xiao, C. A. Tormey, A. Capetillo, R. W. Maitta, Allergic transfusion reactions to platelets are more commonly associated with prepooled than apheresis components, Vox Sanguinis, 2013, 105, 4
  5. 5
    Wm. Andrew Heaton, Costs and benefits of PAS platelets: A mix of science, quality, and value, Transfusion, 2013, 53, 11
  6. 6
    Seema Kacker, Paul M. Ness, William J. Savage, Kevin D. Frick, Jeffrey McCullough, Karen E. King, Aaron A.R. Tobian, The cost-effectiveness of platelet additive solution to prevent allergic transfusion reactions, Transfusion, 2013, 53, 11
  7. 7
    María Luisa Lozano, José Rivera, Vicente Vicente, Concentrados de plaquetas procedentes de sangre total (buffy coat) u obtenidos por aféresis; ¿qué producto emplear?, Medicina Clínica, 2012, 138, 12, 528

    CrossRef

  8. 8
    Matthew Karafin, Alice K. Fuller, William J. Savage, Karen E. King, Paul M. Ness, Aaron A.R. Tobian, The impact of apheresis platelet manipulation on corrected count increment, Transfusion, 2012, 52, 6
  9. 9
    Augusto B. Federici, Chiara Vanelli, Luisa Arrigoni, Transfusion issues in cancer patients, Thrombosis Research, 2012, 129, S60

    CrossRef

  10. 10
    Elizabeth B. Davidow, Benjamin Brainard, Linda G. Martin, Matthew W. Beal, Arthur Bode, Michael J. Ford, Noel Ramsey, Alicia Fagella, Ari Jutkowitz, Use of fresh platelet concentrate or lyophilized platelets in thrombocytopenic dogs with clinical signs of hemorrhage: a preliminary trial in 37 dogs, Journal of Veterinary Emergency and Critical Care, 2012, 22, 1
  11. 11
    Hidefumi Kato, Shigeru Takamoto, Chikako Odaka, Kimitaka Sagawa, Yasutaka Hoshi, Yasuhiko Fujii, Yuji Yonemura, Noriaki Iwao, Asashi Tanaka, Hitoshi Okazaki, Shun-ya Momose, Junichi Kitazawa, Hiroshi Mori, Akio Matsushita, Hisako Nomura, Hitoshi Yasoshima, Yasushi Ookusa, Yoshiaki Okada, Isao Hamaguchi, Kazunari Yamaguchi, ANALYSIS OF TRANSFUSION-RELATED ADVERSE EVENTS BASED ON A PILOT STUDY -TOWARD A COMPREHENSIVE HEMOVIGILANCE SYSTEM FOR JAPAN-, Japanese Journal of Transfusion and Cell Therapy, 2011, 57, 3, 178

    CrossRef

  12. 12
    William J. Savage, Aaron A.R. Tobian, Jessica H. Savage, Robert G. Hamilton, Paul M. Ness, Atopic predisposition of recipients in allergic transfusion reactions to apheresis platelets, Transfusion, 2011, 51, 11
  13. You have free access to this content13
    J. Kjeldsen-Kragh, Challenges in testing for platelet-related adverse events, ISBT Science Series, 2011, 6, 1
  14. You have free access to this content14
    T. B. Gernsheimer, Platelet transfusion in the 21st century: where we’ve been and where we’re going, ISBT Science Series, 2011, 6, 1
  15. 15
    Aaron A.R. Tobian, William J. Savage, Daniel J. Tisch, Sandra Thoman, Karen E. King, Paul M. Ness, Prevention of allergic transfusion reactions to platelets and red blood cells through plasma reduction, Transfusion, 2011, 51, 8
  16. 16
    Monique P. Gelderman, Xuan Chi, Li Zhi, Jaroslav G. Vostal, Ultraviolet B light–exposed human platelets mediate acute lung injury in a two-event mouse model of transfusion, Transfusion, 2011, 51, 11
  17. 17
    H. Schrezenmeier, E. Seifried, Buffy-coat-derived pooled platelet concentrates and apheresis platelet concentrates: which product type should be preferred?, Vox Sanguinis, 2010, 99, 1
  18. 18
    Seth Eisenberg, Refractory Response to Platelet Transfusion Therapy, Journal of Infusion Nursing, 2010, 33, 2, 89

    CrossRef

  19. 19
    Eleanor M. Pullenayegum, Richard J. Cook, The analysis of treatment effects for recurring episodic conditions, Statistics in Medicine, 2010, 29, 14
  20. 20
    Patricia A. Branowicki, Kathleen E. Houlahan, Susanne B. Conley, Oncology of Infancy and Childhood, 2009,

    CrossRef

  21. 21
    Jean C. Osselaer, Nathalie Messe, Tor Hervig, Jose Bueno, Emma Castro, Aurora Espinosa, Patrizia Accorsi, Klaus Junge, Michele Jacquet, Jocelyne Flament, Laurence Corash, A prospective observational cohort safety study of 5106 platelet transfusions with components prepared with photochemical pathogen inactivation treatment, Transfusion, 2008, 48, 6
  22. 22
    J. C. Osselaer, J. P. Cazenave, M. Lambermont, O. Garraud, M. Hidajat, L. Barbolla, R. Tardivel, L. Defoin, C. Waller, I. Mendel, J. P. Raidot, G. Kandel, R. De Meuter, P. Fabrigli, D. Dehenau, J. L. Arroyo, F. Padrón, H. Gouezec, M. Corral, M. Jacquet, D. Sundin, L. Lin, L. Corash, An active haemovigilance programme characterizing the safety profile of 7437 platelet transfusions prepared with amotosalen photochemical treatment, Vox Sanguinis, 2008, 94, 4
  23. 23
    Nancy M. Heddle, Donald M. Arnold, Diana Boye, Kathryn E. Webert, Ilona Resz, Larry J. Dumont, Comparing the efficacy and safety of apheresis and whole blood–derived platelet transfusions: a systematic review, Transfusion, 2008, 48, 7
  24. 24
    Aaron A. R. Tobian, Karen E. King, Paul M. Ness, Prevention of febrile nonhemolytic and allergic transfusion reactions with pretransfusion medication: is this evidence-based medicine?, Transfusion, 2008, 48, 11
  25. 25
    H. J. Alter, H. G. Klein, The hazards of blood transfusion in historical perspective, Blood, 2008, 112, 7, 2617

    CrossRef

  26. 26
    David F. Stroncek, Pulmonary Transfusion Reactions, Seminars in Hematology, 2007, 44, 1, 2

    CrossRef

  27. 27
    Aaron A.R. Tobian, Karen E. King, Paul M. Ness, Transfusion premedications: a growing practice not based on evidence, Transfusion, 2007, 47, 6
  28. 28
    G. Andreu, J. Vasse, I. Sandid, R. Tardivel, G. Semana, Use of random versus apheresis platelet concentrates, Transfusion Clinique et Biologique, 2007, 14, 6, 514

    CrossRef

  29. 29
    Rut Norda, Elsa Tynell, Olof ??kerblom, Cumulative Risks of Early Fresh Frozen Plasma, Cryoprecipitate and Platelet Transfusion in Europe, The Journal of Trauma: Injury, Infection, and Critical Care, 2006, 60, Supplement, S41

    CrossRef

  30. 30
    Harvey G. Klein, Blood Substitutes, 2006,

    CrossRef

  31. 31
    Karin Janetzko, Jean-Pierre Cazenave, Harald Klüter, Daniel Kientz, Martine Michel, Photis Beris, Bruno Lioure, Jan Hastka, Stephane Marblie, Veronique Mayaudon, Lily Lin, Jin-Sying Lin, Maureen G. Conlan, Jocelyne Flament, Therapeutic efficacy and safety of photochemically treated apheresis platelets processed with an optimized integrated set, Transfusion, 2005, 45, 9
  32. 32
    Judy H. Angelbeck, Girolamo A. Ortolano, Universal Leukocyte Reduction, Journal of Infusion Nursing, 2005, 28, 4, 273

    CrossRef

  33. 33
    Lise Estcourt, Simon Stanworth, Carolyn Doree, Sally Hopewell, Michael F Murphy, Alan Tinmouth, Nancy Heddle, Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation, The Cochrane Library,
  34. 34
    Some Unfavourable Effects of Transfusion,